{"text": "RT @ByAmyBrown: Donanemab has much still to prove: my take on the Trailblazer-Alz study, via @evaluatevantage  https://t.co/5EKYGjV3uN $LLY\u2026", "created_at": "2021-03-13T17:11:15.000Z", "id": "1370784533969313795", "author_id": "14673628"}
{"text": "$LLY\nLilly's donanemab slowed Alzheimer's disease progression in Phase 2 trial: full data presented at AD/PD\u2122 2021 and published in NEJM", "created_at": "2021-03-13T17:43:29.000Z", "id": "1370792644486459392", "author_id": "1265655689935896577"}
{"text": "RT @adamfeuerstein: Eli Lilly $LLY releases detailed results on Alzheimer\u2019s drug, as data divide researchers https://t.co/3cNu9n6C2h via @m\u2026", "created_at": "2021-03-13T14:33:52.000Z", "id": "1370744925785108486", "author_id": "430652259"}
{"author_id": "733717446", "created_at": "2021-03-13T13:50:31.000Z", "text": "RT @ByAmyBrown: $LLY\u2019s donanemab scrapes a win in Trailblazer-Alz but the details will surely disappoint: p=0.04 for that 32% relative decl\u2026", "id": "1370734018703003649"}
{"text": "RT @MSollender: $LLY Donanemab in Early Alzheimer\u2019s Disease\n\nhttps://t.co/LmpCQONmhG", "created_at": "2021-03-13T20:43:18.000Z", "id": "1370837898547900416", "author_id": "56152416"}
{"text": "RT @matthewherper: The debate over $LLY's positive Alzheimer's study is fierce.\n\n@adamfeuerstein and I have details here.\n\nhttps://t.co/BEj\u2026", "created_at": "2021-03-13T15:28:50.000Z", "id": "1370758761237778432", "author_id": "13493142"}
{"author_id": "935446829730291717", "created_at": "2021-03-13T06:37:06.000Z", "text": "RT @UncleBillyMoney: $ENZC\n\nMonumental discoveries &amp; advancements w MONOCLONAL ANTIBODIES USING #AI: THE FUTURE OF MEDICINE \n\nCOO tags big\u2026", "id": "1370624943801655297"}
